Clinico-epidemiological features of infections caused by CTX-M type extended spectrum beta lactamase-producing Escherichia coli in hospitalised patients
Authors:
- 1 January 2007
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 54 (1) , 46-52
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UKJournal of Antimicrobial Chemotherapy, 2004
- Emergence of CTX-M β-lactamase-producing Enterobacteriaceae in Portugal: report of an Escherichia coli isolate harbouring blaCTX-M-14Clinical Microbiology and Infection, 2004
- Extended-spectrum β-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, BulgariaClinical Microbiology and Infection, 2004
- Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum -LactamasesClinical Infectious Diseases, 2004
- CTX-M enzymes are the most common extended-spectrum -lactamases among Escherichia coli in a tertiary Greek hospitalJournal of Antimicrobial Chemotherapy, 2004
- Ambler Class A Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella spp. in Canadian HospitalsAntimicrobial Agents and Chemotherapy, 2004
- Growing Group of Extended-Spectrum β-Lactamases: the CTX-M EnzymesAntimicrobial Agents and Chemotherapy, 2004
- Prevalence and Molecular Epidemiology of CTX-MExtended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in RussianHospitalsAntimicrobial Agents and Chemotherapy, 2003
- Investigation of extended-spectrum β-lactamase in Klebsiellae pneumoniae and Escherichia coli from ChinaDiagnostic Microbiology and Infectious Disease, 2002
- Ceftazidime-hydrolysing CTX-M-15 extended-spectrum beta-lactamase (ESBL) in PolandJournal of Antimicrobial Chemotherapy, 2002